GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Chengdu Kanghua Biological Products Co Ltd (SZSE:300841) » Definitions » Future Policy Benefits

Chengdu Kanghua Biological Products Co (SZSE:300841) Future Policy Benefits


View and export this data going back to 2020. Start your Free Trial

What is Chengdu Kanghua Biological Products Co Future Policy Benefits?

Future Policy Benefits only applies to insurance companies.


Chengdu Kanghua Biological Products Co (SZSE:300841) Business Description

Traded in Other Exchanges
N/A
Address
No. 182, Beijing Road, Chengdu Economic and Technological Development Zone, Sichuan Province, Chengdu, CHN, 610100
Chengdu Kanghua Biological Products Co Ltd is engaged in research, development, production, sales and technical services of biological products for prevention, and the existing products include Group ACYW135 Meningococcal Polysaccharide Vaccine-Maikexin, Rabies Vaccine (human diploid cell) for Human Use, freeze-dried - HDCV. The company's products include ACYW135 Meningococcal Polysaccharide Vaccine; and Rabies Vaccine.
Executives
Sun Wan Feng Executives
Hou Wen Li Directors, executives
Wu Wen Nian Executives
Chen Huai Gong Executives
Li Sheng You Executives
Wang Qing Han Directors, executives
Li Xiao Wen Supervisors